Arev Nanotec Brands Stock Performance
| AREVF Stock | USD 0.0005 0.00 0.00% |
The firm shows a Beta (market volatility) of 2.91, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, AREV NanoTec will likely underperform. At this point, AREV NanoTec Brands has a negative expected return of -1.46%. Please make sure to confirm AREV NanoTec's variance, as well as the relationship between the skewness and day typical price , to decide if AREV NanoTec Brands performance from the past will be repeated in the future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days AREV NanoTec Brands has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in January 2026. The current disturbance may also be a sign of long-run up-swing for the company stockholders. ...more
AREV |
AREV NanoTec Relative Risk vs. Return Landscape
If you would invest 1.00 in AREV NanoTec Brands on September 28, 2025 and sell it today you would lose (0.95) from holding AREV NanoTec Brands or give up 95.0% of portfolio value over 90 days. AREV NanoTec Brands is currently producing negative expected returns and takes up 11.7833% volatility of returns over 90 trading days. Put another way, most equities are less risky on the basis of their return distribution than AREV, and majority of traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
AREV NanoTec Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for AREV NanoTec's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as AREV NanoTec Brands, and traders can use it to determine the average amount a AREV NanoTec's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.124
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | AREVF |
Based on monthly moving average AREV NanoTec is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of AREV NanoTec by adding AREV NanoTec to a well-diversified portfolio.
AREV NanoTec Fundamentals Growth
AREV Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of AREV NanoTec, and AREV NanoTec fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on AREV Pink Sheet performance.
| Return On Equity | -16.92 | |||
| Return On Asset | -2.64 | |||
| Operating Margin | (9.24) % | |||
| Current Valuation | 1.53 M | |||
| Shares Outstanding | 31.54 M | |||
| Price To Book | 1.60 X | |||
| Price To Sales | 13.38 X | |||
| Revenue | 255 K | |||
| EBITDA | (797.63 K) | |||
| Cash And Equivalents | 11.23 K | |||
| Total Debt | 55.1 K | |||
| Debt To Equity | 2.38 % | |||
| Book Value Per Share | (0.03) X | |||
| Cash Flow From Operations | (1.47 M) | |||
| Earnings Per Share | (0.03) X | |||
| Total Asset | 622.57 K | |||
About AREV NanoTec Performance
By analyzing AREV NanoTec's fundamental ratios, stakeholders can gain valuable insights into AREV NanoTec's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if AREV NanoTec has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if AREV NanoTec has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
AREV Life Sciences Global Corp., an integrated life science discovery company, produces and sells functional ingredients in Canada. AREV Life Sciences Global Corp. was incorporated in 2005 and is based in Coquitlam, Canada. Arev Life is traded on OTC Exchange in the United States.Things to note about AREV NanoTec Brands performance evaluation
Checking the ongoing alerts about AREV NanoTec for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for AREV NanoTec Brands help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| AREV NanoTec Brands generated a negative expected return over the last 90 days | |
| AREV NanoTec Brands has high historical volatility and very poor performance | |
| AREV NanoTec Brands has some characteristics of a very speculative penny stock | |
| AREV NanoTec Brands has accumulated 55.1 K in total debt with debt to equity ratio (D/E) of 2.38, implying the company greatly relies on financing operations through barrowing. AREV NanoTec Brands has a current ratio of 0.12, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist AREV NanoTec until it has trouble settling it off, either with new capital or with free cash flow. So, AREV NanoTec's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like AREV NanoTec Brands sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for AREV to invest in growth at high rates of return. When we think about AREV NanoTec's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the revenue of 255 K. Net Loss for the year was (990.31 K) with profit before overhead, payroll, taxes, and interest of 190.58 K. | |
| AREV NanoTec Brands has accumulated about 11.23 K in cash with (1.47 M) of positive cash flow from operations. | |
| Roughly 14.0% of AREV NanoTec shares are held by company insiders |
- Analyzing AREV NanoTec's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether AREV NanoTec's stock is overvalued or undervalued compared to its peers.
- Examining AREV NanoTec's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating AREV NanoTec's management team can have a significant impact on its success or failure. Reviewing the track record and experience of AREV NanoTec's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of AREV NanoTec's pink sheet. These opinions can provide insight into AREV NanoTec's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for AREV Pink Sheet analysis
When running AREV NanoTec's price analysis, check to measure AREV NanoTec's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AREV NanoTec is operating at the current time. Most of AREV NanoTec's value examination focuses on studying past and present price action to predict the probability of AREV NanoTec's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AREV NanoTec's price. Additionally, you may evaluate how the addition of AREV NanoTec to your portfolios can decrease your overall portfolio volatility.
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |